Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909387 · ClinicalTrials.gov registry record · NA
Adapting Project UPLIFT for Blacks in Georgia
A NA study of Epilepsy and Depressive Symptoms, sponsored by Morehouse School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT02909387 is a NA study of Epilepsy and Depressive Symptoms that has completed, run by Morehouse School of Medicine. The registered enrollment target is 82 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02909387, a NA study of Epilepsy and Depressive Symptoms, has completed, sponsored by Morehouse School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the efficacy of Project UPLIFT for reducing symptoms of depression and anxiety among African Americans at immediate posttest and after 3 months.
Conditions Studied
Interventions
- BEHAVIORAL Project UPLIFT
Study Locations (1)
Georgia
- Morehouse School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2016-09-08 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02909387
The ClinicalTrials.gov registry entry for NCT02909387 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (91% lower). The listed sponsor is Morehouse School of Medicine, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Project UPLIFT is the first listed.
NCT02909387 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02909387 about?
NCT02909387 is a clinical study titled "Adapting Project UPLIFT for Blacks in Georgia". Evaluate the efficacy of Project UPLIFT for reducing symptoms of depression and anxiety among African Americans at immediate posttest and after 3 months.
What is the current status of trial NCT02909387?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2016-09-08. Estimated completion is 2019-09-30.
What conditions does trial NCT02909387 study?
This clinical trial studies the following conditions: Epilepsy, Depressive Symptoms, Anxiety Disorders and Symptoms.
What interventions are being tested in trial NCT02909387?
The interventions under investigation include: Project UPLIFT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02909387?
This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02909387 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SeizEAR Safety Study
RECRUITING · NA
-
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
RECRUITING · NA
-
Subcortical Arousal in Perceptual Awareness
RECRUITING · NA
-
Prediction of Anxiety and Memory State
RECRUITING · NA
-
Implementation and Cost Evaluation of Project UPLIFT
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.